Benzocaine for boils
This article was originally published in The Tan Sheet
FDA schedules "OTC feedback" meeting with Del Pharmaceuticals for April 21 to discuss the company's studies to support the use of benzocaine to relieve pain and discomfort associated with boils. FDA's November 1993 OTC boil treatment final rule did not include any monograph ingredients ("The Tan Sheet" Nov. 15, 1993, p. 4)
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC